Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors
1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
2Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
3Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
4Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
5Laboratory of Clinical Microbiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
6Center for Neuroimmunology and Health Longevity, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
7Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
收起